Blockchain Registration Transaction Record

GeoVax CEO to Discuss Resilient Infectious Disease Preparedness in May 28 Webinar

GeoVax CEO David Dodd to present on resilient infectious disease preparedness strategy using MVA-based vaccine technologies in May 28 webinar. Learn about platform-based solutions for Ebola, Marburg, Hantavirus, Mpox threats.

This news matters because it addresses the critical need for a proactive, platform-based approach to infectious disease preparedness rather than reactive responses. With recent outbreaks of Ebola, Marburg, Mpox, and Hantavirus exposing vulnerabilities in global health infrastructure, GeoVax's MVA-based vaccine technology could offer a versatile and scalable solution. The webinar provides an opportunity for stakeholders to understand how such technologies can bridge gaps in biodefense and ensure readiness for future pandemics, directly impacting public health security and vaccine supply chains.